Tazi Asmaa, Réglier-Poupet Hélène, Raymond Josette, Adam Jean-Marie, Trieu-Cuot Patrick, Poyart Claire
Groupe Hospitalier Cochin-Saint Vincent de Paul, Service de Bactériologie, Assistance Publique-Hôpitaux de Paris, 27 rue du Faubourg Saint Jacques, Paris, France.
J Antimicrob Chemother. 2007 Jun;59(6):1109-13. doi: 10.1093/jac/dkm098. Epub 2007 Apr 17.
Intrapartum antibiotic prophylaxis is recommended to prevent neonatal group B streptococcal (GBS) disease in colonized women, and penicillin or aminopenicillin constitute the first-line antibiotics. Most isolates are resistant to tetracycline, and resistance to macrolide-lincosamide-streptogramin (MLS) antibiotics is increasing. Therefore, laboratory testing for MLS resistance in GBS is now recommended for penicillin-allergic patients. The aim of this study was to compare the antimicrobial susceptibility of GBS as determined by the VITEK 2 system (bioMérieux, Marcy l'Etoile, France), agar diffusion methods and PCR-genotypic detection of resistance genes.
One hundred and ten unrelated selected GBS clinical isolates were studied. The antibiotics tested (VITEK 2 and agar diffusion method) were benzylpenicillin, ampicillin, erythromycin, clindamycin, co-trimoxazole, tetracycline, kanamycin, streptomycin and vancomycin. A standardized double-disc (DD) diffusion test was performed for MLS antibiotics. Genotypic characterization of tetracycline, MLS and aminoglycoside resistance genes was performed by PCR.
All strains were susceptible to benzylpenicillin, ampicillin and vancomycin [category agreement (CA) between VITEK 2 and the diffusion method was 100%]. Ninety-five (86%) strains were resistant to tetracycline (CA was 98.9%). Eighty-one strains (73.6%) harboured an MLS resistance phenotype; 50 (61.8%) an MLS(B)-constitutive phenotype, 25 (30.8%) an MLS(B)-inducible phenotype and 6 (7.4%) an M phenotype. The agreement between data of VITEK 2 and the DD diffusion test for the detection of MLS(B)-constitutive, MLS(B)-inducible and M phenotype isolates was 76%, 36% and 100%, respectively. Almost all discrepancies were due to failure to detect erythromycin resistance by VITEK 2.
VITEK 2 allows accurate determination of GBS susceptibility for the majority of antibiotics, but has to be improved for erythromycin. Thus, the DD diffusion test remains the most simple and reliable method for macrolide resistance detection among this streptococcal species.
推荐在分娩期进行抗生素预防以预防定植妇女的新生儿B族链球菌(GBS)疾病,青霉素或氨基青霉素是一线抗生素。大多数分离株对四环素耐药,对大环内酯-林可酰胺-链阳霉素(MLS)抗生素的耐药性正在增加。因此,现在建议对青霉素过敏的患者进行GBS中MLS耐药性的实验室检测。本研究的目的是比较VITEK 2系统(法国马西伊图瓦勒生物梅里埃公司)、琼脂扩散法和耐药基因的PCR基因型检测所确定的GBS抗菌敏感性。
研究了110株不相关的选定GBS临床分离株。所检测的抗生素(VITEK 2和琼脂扩散法)有苄青霉素、氨苄青霉素、红霉素、克林霉素、复方新诺明、四环素、卡那霉素、链霉素和万古霉素。对MLS抗生素进行标准化双碟(DD)扩散试验。通过PCR对四环素、MLS和氨基糖苷类耐药基因进行基因型鉴定。
所有菌株对苄青霉素、氨苄青霉素和万古霉素敏感[VITEK 2与扩散法之间的类别一致性(CA)为100%]。95株(86%)菌株对四环素耐药(CA为98.9%)。81株(73.6%)具有MLS耐药表型;50株(61.8%)为MLS(B)组成型表型,25株(30.8%)为MLS(B)诱导型表型,6株(7.4%)为M表型。VITEK 2数据与DD扩散试验检测MLS(B)组成型、MLS(B)诱导型和M表型分离株的数据之间的一致性分别为76%、36%和100%。几乎所有差异都是由于VITEK 2未能检测到红霉素耐药性。
VITEK 2能够准确测定大多数抗生素对GBS的敏感性,但对红霉素检测有待改进。因此,DD扩散试验仍然是检测该链球菌属大环内酯耐药性最简单可靠的方法。